Rusfertide clinical trials
Also written PTG-300 and TAK-121.
How each study uses rusfertide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the rusfertide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2019 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test rusfertide.
- Oct 2027A Study of Rusfertide in Japanese Adults With Polycythemia VeraPhase 2 · Takeda
Studies
Open first, then newest update. How each study uses rusfertide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Study of Rusfertide in Japanese Adults With Polycythemia VeraRecruitingPhase 2TakedaNCT07648030Written as Rusfertide
- A Study of Rusfertide in Adults With Polycythemia Vera in ChinaNot yet recruitingPhase 2TakedaNCT07765602Written as Rusfertide
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Active, not recruitingPhase 3Protagonist Therapeutics, Inc.NCT05210790Written as Rusfertide
- PTG-300 in Subjects With Hereditary HemochromatosisCompletedPhase 2Protagonist Therapeutics, Inc.NCT04202965Written as PTG-300
- Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)CompletedPhase 2Protagonist Therapeutics, Inc.NCT04057040Written as PTG-300
- PTG-300 in Patients With Polycythemia Vera and Elevated HematocritCompletedPhase 2Protagonist Therapeutics, Inc.NCT04767802Written as PTG-300
- Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy VolunteersCompletedPhase 1Protagonist Therapeutics, Inc.NCT04516382Written as PTG-300
- Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic AnemiaCompletedPhase 2Protagonist Therapeutics, Inc.NCT03802201Written as PTG-300
- Safety Study for Beta Thalassemia Subjects on PTG-300CompletedPhase 2Protagonist Therapeutics, Inc.NCT04054921Written as PTG-300
Codes
What other systems call rusfertide · ClinicalTrials.gg INT018480
- UNII (FDA) XM71MYX0IQRUSFERTIDEConfirmed FDA, Wikidata
- Wikidata Q126717527rusfertideConfirmed FDA, Wikidata
- NCI Thesaurus C162883RusfertideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XM71MYX0IQ | RUSFERTIDE | Confirmed FDA, Wikidata |
| Wikidata | Q126717527 | rusfertide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C162883 | Rusfertide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.